1. Tamakoshi A, Lin Y, Ohno Y. Mortality and incidence of pancreatic cancer.Sogorinsho 1999; 48: 1640–1648. (in Japanese)
2. Bida GT, Satyamurthy N, Barrio JR. The synthesis of 2-[F-18] fluoro-2-deoxy-d-glucose using glycals: a reexamination.J Nucl Med 1984; 25: 1327–1334.
3. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool.Invest Radiol 1986; 22: 360–371.
4. Strauss LG, Conti PS. The applications of PET in clinical oncology.J Nucl Med 1991; 32: 623–648; discussion 649–650.
5. Zimny M, Bares R, Fass J, Adam G, Cremerius U, Dohmen B, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.Eur J Nucl Med 1997; 24: 678–682.